The U.S. Food and Drug Administration has imposed a clinical hold on BioNTech's investigational malaria vaccine trial, temporarily halting the study's progression.
Scientists at Oregon Health & Science University have developed a novel malaria vaccine that eliminated 75-80% of parasites in vaccinated rhesus macaques, offering a potential breakthrough in the fight against a disease that kills nearly 500,000 people annually.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.